Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

Kaposi's sarcoma lesions might originate from benign tissue changes.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

The document provides 70 multiple choice questions to improve haematology skills.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Targeting the Smoothened receptor shows promise for treating certain cancers.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Recognizing rare tumor combinations is crucial for accurate diagnosis and treatment.

BST2 protein and certain T cells increase in early alopecia areata.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Lipid-antigen stimulation may play a role in folliculotropic mycosis fungoides.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Ocrelizumab may cause pancreatitis in some patients.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.